Evaluation of the impact of treatment delays and dose reductions on tumor response in human ovarian cancer xenograft models

被引：0
|
作者：
Hong, Jing [1 ]
Saucier, Jenifer M. [2 ]
Gaikwad, Anjah [2 ]
Brown, Jubilee [2 ]
Smith, Judith A. [1 ,2 ,3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Univ Texas Hlth Sci Ctr Houston, Houston Med Sch, Houston, TX USA
来源：
REPRODUCTIVE SCIENCES | 2008年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
860
引用
收藏
页码：302A / 302A
页数：1
相关论文
共 50 条
  • [31] The impact of dose delays and reductions on progression free survival (PFS) in older patients with metastatic breast cancer receiving palbocilib
    Karuturi, M.
    Katherine, C.
    Kimmel, J.
    Yi, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S111 - S111
  • [32] Inhibitors of fibrosis and TGF-beta delay tumor xenograft growth and reduce ascites in ovarian cancer models
    Zhang, Qing
    Hou, Xiaonan
    Evans, Bradley J.
    Weroha, John J.
    Cliby, William A.
    CANCER RESEARCH, 2017, 77
  • [33] The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor Models
    Mueller, Thomas
    Pfankuchen, Daniel Bastian
    von Rekowski, Kathleen Wantoch
    Schlesinger, Martin
    Reipsch, Franziska
    Bendas, Gerd
    MOLECULES, 2017, 22 (05):
  • [34] The anti-tumor effect of activated natural killer cells in xenograft mouse models with epithelial ovarian cancer
    Young, Mo Jin
    Kyoung-Jin, Lee
    Yoo-Kyeong, Whang
    Shin-Wha, Lee
    Yong-Man, Kim
    Dae-Yeon, Kim
    Jong-Hyeok, Kim
    Joo-Hyun, Nam
    Young-Tak, Kim
    CANCER RESEARCH, 2012, 72
  • [35] ENGRAFTMENT OPTIMIZATION, CHARACTERIZATION AND TUMOR SPREAD TRACKING BY PRECLINICAL IMAGING IN OVARIAN CANCER PATIENT DERIVED XENOGRAFT MODELS
    Kleinmanns, K.
    Anandan, S.
    Bischof, K.
    Karlson, I. Tveit
    Popa, M.
    Mc Cormack, E.
    Bjorge, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1545 - 1545
  • [36] Association of AMPK signaling pathway with tumor response to treatment in ovarian cancer
    Madi, H. M.
    Al-Wahab, Z.
    Poisson, L.
    Burmeister, C.
    Alford, S. Hensley
    Morris, R. T.
    Rattan, R.
    Munkarah, A. R.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 178 - 178
  • [37] Novel Stably Transplantable Xenograft Models of Human Breast Cancer for Evaluation of Experimental Therapeutics
    Dobrolecki, L. E.
    Landis, M. D.
    Zhang, X.
    Huang, J.
    Lai, Q.
    Wong, H.
    Contreras, A.
    Chang, J. C. N.
    Lewis, M. T.
    CANCER RESEARCH, 2009, 69 (24) : 589S - 589S
  • [38] Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model
    Geller, Melissa A.
    Knorr, David A.
    Hermanson, David A.
    Pribyl, Lee
    Bendzick, Laura
    McCullar, Valarie
    Miller, Jeffrey S.
    Kaufman, Dan S.
    CYTOTHERAPY, 2013, 15 (10) : 1297 - 1306
  • [39] Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer
    Fontana, Luigi
    Adelaiye, Remi M.
    Rastelli, Antonella L.
    Miles, Kiersten Marie
    Ciamporcero, Eric
    Longo, Valter D.
    Nguyen, Holly
    Vessella, Robert
    Pili, Roberto
    ONCOTARGET, 2013, 4 (12) : 2451 - 2461
  • [40] Tumor-Derived Exosomes Promote Tumor Growth Through Modulating Microvascular Hemodynamics in a Human Ovarian Cancer Xenograft Model
    Wang, Qin
    Zhang, Xiaoyan
    Li, Bingwei
    Liu, Xueting
    Li, Ailing
    Li, Hongwei
    Shi, Xiaohua
    Han, Jianqun
    MICROCIRCULATION, 2024, 31 (07)
12345